Sharing Our New Ad With You – COVID-19
"Rise," a 30-second ad by NACDS, captures the spirit and resolve of member companies, their teams, their customers, their communities and our nation - amid COVID-19 and throughout time.
NACDS Op-ed in Morning Consult: DIR Fees “as Damaging to Patients and Pharmacies as Advertised”
NACDS' opinion piece cites a Drug Channels Institute analysis that DIR fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019.
NACDS Cites Harvard Business Review Article to Advance Roles of Pharmacists, Pharmacy Technicians
Medium post extends reach of findings by Kaiser Permanente
Pharmacy Value in Harvard Business Review Article
The 300,000+ influential readers of Harvard Business Review are seeing pharmacists positioned as part of the solution to high-quality and affordable healthcare.
New York Times Pharmacy Story
Read the complete statement provided to The New York Times in January 2020.
Americans’ Trust in Pharmacists Should Speak Volumes to Government, NACDS Says
Pharmacists strong again in latest Gallup “honesty and ethics” survey
